Castle Creek Arbitrage’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Castle Creek Arbitrage’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200,000	Closed	-$2.01M	–	493
2022 Q4	$2.01M	Hold	200,000	–	–	0.18%	151
2022 Q3	$1.96M	Hold	200,000	–	–	0.11%	245
2022 Q2	$1.96M	Hold	200,000	–	–	0.11%	251
2022 Q1	$1.95M	Hold	200,000	–	–	0.1%	257
2021 Q4	$1.95M	Hold	200,000	–	–	0.1%	256
2021 Q3	$1.94M	Hold	200,000	–	–	0.11%	211
2021 Q2	$1.95M	Buy	+200,000	New	+$1.96M	0.11%	219

Other funds holding AONC

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Castle Creek Arbitrage's AONC Position: Q1 2023 in Review

Castle Creek Arbitrage sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 200,000 shares — an estimated $2.01M sold.

Castle Creek Arbitrage first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $2.01M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

Castle Creek Arbitrage reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 200,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $2.01M.
Castle Creek Arbitrage first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
Castle Creek Arbitrage's American Oncology Network, Inc. Class A Common Stock position peaked at $2.01M in Q4 2022.
13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Castle Creek Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.